Enterprise Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $33M

  • Investors
  • 7

Enterprise Therapeutics General Information

Description

Operator of a drug discovery and development firm intended to develop novel therapies for the treatment of respiratory diseases. The company specializes in developing and discovering new disease-modifying therapies for diseases such as cystic fibrosis, asthma, and COPD, thereby reducing the frequency of lung infections and improving the patient's quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Sussex Innovation Centre
  • University of Sussex, Science Park Square, Falmer
  • Brighton BN1 9SB
  • England, United Kingdom
+44 01273 000000

Enterprise Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enterprise Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 30-Jan-2024 $33M 0000 Completed Generating Revenue
9. Secondary Transaction - Private 0000 Completed Generating Revenue
8. Later Stage VC 09-Mar-2022 00.000 0000 Completed Generating Revenue
6. Secondary Transaction - Private 06-Oct-2020 000.00 0000 Completed Generating Revenue
5. Grant 15-Oct-2019 00.000 0000 Completed Generating Revenue
4. Early Stage VC (Series B) 06-Apr-2018 000.00 0000 000.00 Completed Generating Revenue
3. Early Stage VC 10-Nov-2016 00.000 000.00 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 20-May-2015 $12.9M $12.9M 000.00 Completed Startup
1. Spin-Off 02-May-2014 Completed Startup
To view Enterprise Therapeutics’s complete valuation and funding history, request access »

Enterprise Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Enterprise Therapeutics’s complete cap table history, request access »

Enterprise Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug discovery and development firm intended to develop novel therapies for the treatment of respiratory d
Drug Discovery
Brighton, United Kingdom
13 As of 2022
0000
00000000000 0000

0000 0

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
0000000000000
Encinitas, CA
000
000000000 000

000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
0000 000000000
Morristown, NJ
0 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enterprise Therapeutics Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vasa Therapeutics Venture Capital-Backed Encinitas, CA 000 000000000 000
Moerae Matrix Formerly VC-backed Morristown, NJ 0 000.00 00000000000 000.00
hVIVO Formerly VC-backed London, United Kingdom 000 00000 000000&0 00000
Aqualung Therapeutics Venture Capital-Backed Tucson, AZ 0 00.00 00000000000 00.00
Verve Therapeutics Formerly VC-backed Boston, MA 000 00000 00000000 00000
You’re viewing 5 of 30 competitors. Get the full list »

Enterprise Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
John Ford Ph.D Chief Executive Officer and Board Member
Martin Gosling Ph.D Co-Founder, Chief Operating Officer & Chief Scientific Officer
Henry Danahay Ph.D Co-Founder & Head of Biology
Niyati Prasad Chief Medical Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Enterprise Therapeutics Board Members (12)

Name Representing Role Since
Alexander Mayweg Ph.D Versant Ventures Board Member 000 0000
Amit Munshi Self Chairman 000 0000
Bart Dzikowski JD Novartis Venture Fund Board Member 000 0000
Craig Richardson Ph.D IP Group Board Member 000 0000
Elizabeth Roper Ph.D Epidarex Capital Board Observer 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Enterprise Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enterprise Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Panakes Partners Venture Capital Minority 000 0000 000000 0
Roche Corporation Minority 000 0000 000000 0
Cystic Fibrosis Foundation Limited Partner 000 0000 000000 0
Forbion Venture Capital Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Enterprise Therapeutics FAQs

  • When was Enterprise Therapeutics founded?

    Enterprise Therapeutics was founded in 2014.

  • Who is the founder of Enterprise Therapeutics?

    Martin Gosling Ph.D and Henry Danahay Ph.D are the founders of Enterprise Therapeutics.

  • Who is the CEO of Enterprise Therapeutics?

    John Ford Ph.D is the CEO of Enterprise Therapeutics.

  • Where is Enterprise Therapeutics headquartered?

    Enterprise Therapeutics is headquartered in Brighton, United Kingdom.

  • What is the size of Enterprise Therapeutics?

    Enterprise Therapeutics has 13 total employees.

  • What industry is Enterprise Therapeutics in?

    Enterprise Therapeutics’s primary industry is Drug Discovery.

  • Is Enterprise Therapeutics a private or public company?

    Enterprise Therapeutics is a Private company.

  • What is Enterprise Therapeutics’s current revenue?

    The current revenue for Enterprise Therapeutics is 000000.

  • How much funding has Enterprise Therapeutics raised over time?

    Enterprise Therapeutics has raised $99M.

  • Who are Enterprise Therapeutics’s investors?

    Panakes Partners, Roche, Cystic Fibrosis Foundation, Forbion, and IP Group are 5 of 7 investors who have invested in Enterprise Therapeutics.

  • Who are Enterprise Therapeutics’s competitors?

    Vasa Therapeutics, Moerae Matrix, hVIVO, Aqualung Therapeutics, and Verve Therapeutics are some of the 30 competitors of Enterprise Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »